Episode Details
Back to EpisodesFDA Vague Efforts to Scale Generative AI Internally By End of June
Description
This episode is brought to you by Semafor Healthcare.
Delivered weekly from David Lim, Semafor Healthcare connects the dots between decisions in government, business, and technology to reveal how they impact the future of healthcare. Each edition will provide the analysis you need to understand and stay ahead of a rapidly changing landscape. Subscribe for free.
Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss the Food and Drug Administration's recent announcement to scale a generative artificial intelligence across its center in the future.
Health Affairs released their first Insider trend report. The report focuses on AI in health care and you can get full access to this report by becoming an Insider. Insiders also will receive access to our June 17 event on risk adjustment trends and our July 7 event featuring a wrap-up of the recent Supreme Court session.
Related Links:
- FDA's plan to roll out AI agencywide raises questions (Axios)
- PRESS RELEASE: FDA Announces Completion of First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout Timeline